213 related articles for article (PubMed ID: 20639899)
21. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
[TBL] [Abstract][Full Text] [Related]
22. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
Sieber T; Dobner T
J Virol; 2007 Jan; 81(1):95-105. PubMed ID: 17050591
[TBL] [Abstract][Full Text] [Related]
24. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2.
Krätzer F; Rosorius O; Heger P; Hirschmann N; Dobner T; Hauber J; Stauber RH
Oncogene; 2000 Feb; 19(7):850-7. PubMed ID: 10702793
[TBL] [Abstract][Full Text] [Related]
25. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
26. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein.
Shen Y; Kitzes G; Nye JA; Fattaey A; Hermiston T
J Virol; 2001 May; 75(9):4297-307. PubMed ID: 11287579
[TBL] [Abstract][Full Text] [Related]
27. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
28. Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.
Janssen K; Hofmann TG; Jans DA; Hay RT; Schulze-Osthoff K; Fischer U
Oncogene; 2007 Mar; 26(11):1557-66. PubMed ID: 16924230
[TBL] [Abstract][Full Text] [Related]
29. The promyelocytic leukemia protein isoform PML1 is an oncoprotein and a direct target of the antioxidant sulforaphane (SFN).
Alhazmi N; Pai CP; Albaqami A; Wang H; Zhao X; Chen M; Hu P; Guo S; Starost K; Hajihassani O; Miyagi M; Kao HY
Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118707. PubMed ID: 32243901
[TBL] [Abstract][Full Text] [Related]
30. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
[TBL] [Abstract][Full Text] [Related]
31. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
[TBL] [Abstract][Full Text] [Related]
32. The adenovirus-2 E1B-55K protein interacts with a mSin3A/histone deacetylase 1 complex.
Punga T; Akusjärvi G
FEBS Lett; 2000 Jul; 476(3):248-52. PubMed ID: 10913622
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus E1B 55K represses p53 activation in vitro.
Martin ME; Berk AJ
J Virol; 1998 Apr; 72(4):3146-54. PubMed ID: 9525640
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.
Harada JN; Shevchenko A; Shevchenko A; Pallas DC; Berk AJ
J Virol; 2002 Sep; 76(18):9194-206. PubMed ID: 12186903
[TBL] [Abstract][Full Text] [Related]
35. The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components.
Leppard KN; Everett RD
J Gen Virol; 1999 Apr; 80 ( Pt 4)():997-1008. PubMed ID: 10211970
[TBL] [Abstract][Full Text] [Related]
36. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
37. An L2 SUMO interacting motif is important for PML localization and infection of human papillomavirus type 16.
Bund T; Spoden GA; Koynov K; Hellmann N; Boukhallouk F; Arnold P; Hinderberger D; Florin L
Cell Microbiol; 2014 Aug; 16(8):1179-200. PubMed ID: 24444361
[TBL] [Abstract][Full Text] [Related]
38. ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation.
Dassouki Z; Sahin U; El Hajj H; Jollivet F; Kfoury Y; Lallemand-Breitenbach V; Hermine O; de Thé H; Bazarbachi A
Blood; 2015 Jan; 125(3):474-82. PubMed ID: 25395419
[TBL] [Abstract][Full Text] [Related]
39. Solubility shift and SUMOylaltion of promyelocytic leukemia (PML) protein in response to arsenic(III) and fate of the SUMOylated PML.
Hirano S; Tadano M; Kobayashi Y; Udagawa O; Kato A
Toxicol Appl Pharmacol; 2015 Sep; 287(3):191-201. PubMed ID: 26049103
[TBL] [Abstract][Full Text] [Related]
40. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
